PKO yields 148.70% · JNJ yields 2.14%● Live data
📍 PKO pulled ahead of the other in Year 1
Combined, PKO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PKO + JNJ for your $10,000?
PIMCO Income Opportunity Fund (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests a substantial portion of assets in a variety of mortgage-related securities and may hold common stocks, including those received from conversion of other portfolio securities. The Fund may invest up to 40% of its total assets in bank loans (including, among others, senior loans, delayed funding loans and revolving credit facilities). The Fund may also invest up to 40% of its total assets in securities of issuers economically tied to emerging market countries. The Fund invests in range of portfolio sectors, which include the United States Government Related, mortgage, non-agency mortgage, high yield credit, emerging markets, emerging markets and other. Pacific Investment Management Company LLC is the investment manager of the Fund.
Full PKO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.